Hisamitsu Pharm Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Hisamitsu Pharm Ltd are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 21, 2019 and ending today September 19, 2019. Click here to learn more.

Hisamitsu Pharm Summary

Hisamitsu Pharm Ltd [HTSUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.34B. Hisamitsu Pharm classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 82.69M outstanding shares. HISAMITSU PHARMAC has accumulated about 1.13B in cash with 221.68M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.46.
Check Hisamitsu Pharm Probability Of Bankruptcy

Hisamitsu Pharm Target Price Odds Analysis

Odds Below 38.5HorizonTargetOdds Above 38.5
98.23%30 days 38.50 1.77%
Based on normal probability distribution, the odds of Hisamitsu Pharm to move above current price in 30 days from now is about 1.77% (This Hisamitsu Pharm Ltd probability density function shows the probability of Hisamitsu Pharm OTC Stock to fall within a particular range of prices over 30 days) .

Hisamitsu Pharm Risk Profiles

Hisamitsu Pharm Key Fundamentals

Hisamitsu Pharm Against Markets

Hisamitsu Pharm Vital Trading Data

Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Hisamitsu Pharm operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 2792 people. more
NameHisamitsu Pharm Ltd
ChairmanHirotaka NakatomiView All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business Address408, Tashiro Daikan-machi
ExchangeBATS Exchange
IndustryDrug Manufacturers - Specialty & Generic
Phone81 9 4283 2101
CurrencyUSD - US Dollar
Next Fiscal Year EndFebruary 28, 2021
Most Recent QuarterMay 31, 2019
Last Fiscal Year EndFebruary 28, 2019

Hisamitsu Pharm Distributions to stockholders

Hisamitsu Pharm Corporate Directors

Toshiaki Tsuruda Executive Officer, Chief Director of Production Environment, Director
Toshihide Kanari Executive Officer, Director of External Affairs, Manager of Public Relations Office
Teijiro Furukawa Non-Executive Independent Director
Please also check Risk vs Return Analysis. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.